GOSS

$0.00

(

0.00%

)
Quote details

stock

Gossamer Bio Inc

NASDAQ | GOSS

3.60

USD

$0.00

(

0.00%

)

At Close (As of Dec 12, 2025)

$833.24M

Market Cap

-

P/E Ratio

-0.69

EPS

$3.80

52 Week High

$0.76

52 Week Low

HEALTHCARE

Sector

GOSS Chart

Recent Chart
Price Action

GOSS Technicals

Tags:

GOSS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $115M
Total Revenue $115M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$60M
Selling General And Administrative $36M
Research And Development $138M
Operating Expenses $175M
Investment Income Net -
Net Interest Income -$9.7M
Interest Income $1.8M
Interest Expense $12M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.2M
Income Before Tax -$56M
Income Tax Expense $893K
Interest And Debt Expense -
Net Income From Continuing Operations -$57M
Comprehensive Income Net Of Tax -
Ebit -$44M
Ebitda -$40M
Net Income -$57M

Revenue & Profitability

Earnings Performance

GOSS Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $115M
Total Revenue $115M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$60M
Selling General And Administrative $36M
Research And Development $138M
Operating Expenses $175M
Investment Income Net -
Net Interest Income -$9.7M
Interest Income $1.8M
Interest Expense $12M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.2M
Income Before Tax -$56M
Income Tax Expense $893K
Interest And Debt Expense -
Net Income From Continuing Operations -$57M
Comprehensive Income Net Of Tax -
Ebit -$44M
Ebitda -$40M
Net Income -$57M

GOSS News

GOSS Profile

Gossamer Bio Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Gossamer Bio, Inc. is a San Diego-based clinical-stage biopharmaceutical firm focused on the discovery and development of innovative therapies for immunology, inflammation, and oncology. With a robust pipeline that employs advanced scientific insights, Gossamer Bio addresses significant unmet medical needs through its diverse range of drug candidates. As it progresses through clinical trials, the company is committed to providing transformative treatment options for patients with complex diseases, establishing itself as an influential player in the biopharmaceutical sector.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CVE
+1.74%
$18.03
CIFR
-9.69%
$17.05
HOOD
-3.14%
$119.50
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
HL
-2.79%
$18.81
JBLU
+1.02%
$4.94
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
AG
-5.17%
$15.94
IBRX
+7.76%
$2.36
NOK
-1.41%
$6.27
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CVE
+1.74%
$18.03
CIFR
-9.69%
$17.05
HOOD
-3.14%
$119.50
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
HL
-2.79%
$18.81
JBLU
+1.02%
$4.94
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
AG
-5.17%
$15.94
IBRX
+7.76%
$2.36
NOK
-1.41%
$6.27
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.